Back
CyberArk Software Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
56
CYBR
CyberArk Software
Last Price:
$318.56
Seasonality Move:
11.42%
Sell
27
DRUG
Bright Minds Biosciences
Last Price:
$38.35
Seasonality Move:
-39.59%
Buy
56
CyberArk Software (CYBR)
is a Buy
Is CyberArk Software a Buy, Sell or Hold?
-
The current CyberArk Software [CYBR] share price is $319.15. The Score for CYBR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
CYBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $38.58. The Score for DRUG is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYBR Stock Price Chart
What is CyberArk Software's stock price today?
-
The CyberArk Software share price today is $319.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYBR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $38.58The current trend is moderately bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
CYBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.72 | Buy |
Relative Strength Index (14 RSI): | 53.31 | Buy |
Chaikin Money Flow: | 389616 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (312.24 - 325.88) | Buy |
Bollinger Bands (100): | (268.33 - 310.43) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 49.17 | Sell |
Chaikin Money Flow: | 25807 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.73 - 42.21) | Sell |
Bollinger Bands (100): | (-0.1 - 41.52) | Buy |
CYBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 316.91 | Buy |
20-day SMA: | 320.22 | Sell |
50-day SMA: | 305.14 | Buy |
200-day SMA: | 271.08 | Buy |
8-day EMA: | 316.53 | Buy |
20-day EMA: | 315.98 | Buy |
50-day EMA: | 306.41 | Buy |
200-day EMA: | 271.83 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.04 | Sell |
20-day SMA: | 39.8 | Sell |
50-day SMA: | 40.28 | Sell |
200-day SMA: | 10.93 | Buy |
8-day EMA: | 39.03 | Sell |
20-day EMA: | 39.39 | Sell |
50-day EMA: | 35 | Buy |
200-day EMA: | 16.73 | Buy |
CyberArk Software Earnings Growth & CYBR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.17 per share, and an increase next year of $0.66 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CyberArk Software Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |